Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in Princeton, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
107
Frequently Asked Questions
What is Market Cap of Y-Mabs Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Y-Mabs Therapeutics Inc market cap is $389.86M.
What is the 52-week high for Y-Mabs Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Y-Mabs Therapeutics Inc 52 week high is $16.11 as of September 12, 2025.
What is the 52-week low for Y-Mabs Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Y-Mabs Therapeutics Inc 52 week low is $3.55 as of September 12, 2025.
What is Y-Mabs Therapeutics Inc stock price today?
Y-Mabs Therapeutics Inc stock price today is $8.59.
What was Y-Mabs Therapeutics Inc stock price yesterday?
Y-Mabs Therapeutics Inc stock price yesterday was $8.58.
What is the PE ratio of Y-Mabs Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Y-Mabs Therapeutics Inc’s P/E ratio is -17.34.
What is the Price-to-Book ratio of Y-Mabs Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Y-Mabs Therapeutics Inc P/B ratio is 4.4559.
What is the 50-day moving average of Y-Mabs Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Y-Mabs Therapeutics Inc 50-day moving average is $6.59.
How many employess does Y-Mabs Therapeutics Inc has?